Jingjing Yu

498 total citations
11 papers, 289 citations indexed

About

Jingjing Yu is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Jingjing Yu has authored 11 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cell Biology. Recurrent topics in Jingjing Yu's work include Extracellular vesicles in disease (2 papers), Cancer-related Molecular Pathways (2 papers) and T-cell and B-cell Immunology (2 papers). Jingjing Yu is often cited by papers focused on Extracellular vesicles in disease (2 papers), Cancer-related Molecular Pathways (2 papers) and T-cell and B-cell Immunology (2 papers). Jingjing Yu collaborates with scholars based in China, United States and Australia. Jingjing Yu's co-authors include Robert J. Linhardt, Michel Weïwer, Jonathan S. Dordick, Jing Zhou, Wei Zhang, Fei Xu, Wei Bai, Gregory A. Fishbein, Mohamad Navab and Atsuko Seki and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and Frontiers in Immunology.

In The Last Decade

Jingjing Yu

10 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Yu China 8 157 57 52 39 36 11 289
Kongyan Niu China 9 267 1.7× 74 1.3× 23 0.4× 45 1.2× 24 0.7× 15 462
Liying Wang China 9 218 1.4× 49 0.9× 44 0.8× 44 1.1× 24 0.7× 20 324
Julia Hoffmann Germany 9 252 1.6× 26 0.5× 66 1.3× 57 1.5× 23 0.6× 13 400
Bo Xia United States 12 244 1.6× 120 2.1× 73 1.4× 49 1.3× 85 2.4× 16 461
Yuanqing Feng China 7 261 1.7× 32 0.6× 34 0.7× 56 1.4× 28 0.8× 9 392
Miki Obata Japan 10 230 1.5× 53 0.9× 44 0.8× 39 1.0× 53 1.5× 13 416
Dorothy H. Crouch United Kingdom 11 272 1.7× 34 0.6× 86 1.7× 46 1.2× 46 1.3× 15 402
Jingchen Shao Germany 8 242 1.5× 42 0.7× 53 1.0× 34 0.9× 25 0.7× 14 364
Jordi Minguillón Spain 8 172 1.1× 81 1.4× 130 2.5× 36 0.9× 46 1.3× 17 371
Henry Kuang United States 9 128 0.8× 50 0.9× 31 0.6× 40 1.0× 29 0.8× 12 277

Countries citing papers authored by Jingjing Yu

Since Specialization
Citations

This map shows the geographic impact of Jingjing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Yu more than expected).

Fields of papers citing papers by Jingjing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Yu. The network helps show where Jingjing Yu may publish in the future.

Co-authorship network of co-authors of Jingjing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Yu. A scholar is included among the top collaborators of Jingjing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Yu. Jingjing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lu, Jin, Lin Yang, Jingjing He, et al.. (2025). Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Systemic Lupus Erythematosus via Glucose Metabolism of CD4+T Cells. Stem Cell Reviews and Reports. 21(4). 1013–1033.
2.
Ji, Jiang, Yue An, Pengfei Ye, et al.. (2024). Angiotensin II type-2 receptor signaling facilitates liver injury repair and regeneration via inactivation of Hippo pathway. Acta Pharmacologica Sinica. 45(6). 1201–1213. 2 indexed citations
3.
Yu, Jingjing, et al.. (2024). CAR immunotherapy in autoimmune diseases: promises and challenges. Frontiers in Immunology. 15. 1461102–1461102. 11 indexed citations
4.
Lei, Xiaocan, Tao Huang, Zhiwei Shen, et al.. (2024). Follicular fluid-derived extracellular vesicles miR-34a-5p regulates granulosa cell glycolysis in polycystic ovary syndrome by targeting LDHA. Journal of Ovarian Research. 17(1). 223–223. 11 indexed citations
5.
Liu, Xia, Jingjing Yu, Longyong Xu, et al.. (2021). Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β−selection. eLife. 10. 22 indexed citations
6.
Yu, Jingjing, Dongjing Yang, Tingting Dong, et al.. (2020). Chilling and Heat Stress-Induced Physiological Changes and MicroRNA-Related Mechanism in Sweetpotato (Ipomoea batatas L.). Frontiers in Plant Science. 11. 687–687. 34 indexed citations
7.
Yu, Jingjing, Jing Zhou, Fei Xu, Wei Bai, & Wei Zhang. (2018). High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer. The International Journal of Biological Markers. 33(2). 215–221. 51 indexed citations
8.
Briot, Anaïs, Mete Civelek, Atsuko Seki, et al.. (2015). Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis. The Journal of Experimental Medicine. 212(12). 2147–2163. 81 indexed citations
9.
Briot, Anaïs, Mete Civelek, Atsuko Seki, et al.. (2015). Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis. The Journal of Cell Biology. 211(4). 2114OIA269–2114OIA269. 2 indexed citations
10.
Zhang, Yu, Yan Tian, Jingjing Yu, et al.. (2013). Overexpression of WDR62 is associated with centrosome amplification in human ovarian cancer. Journal of Ovarian Research. 6(1). 55–55. 22 indexed citations
11.
Yu, Jingjing, Michel Weïwer, Robert J. Linhardt, & Jonathan S. Dordick. (2008). The Role of the Methoxyphenol Apocynin, a Vascular NADPH Oxidase Inhibitor, as a Chemopreventative Agent in the Potential Treatment of Cardiovascular Diseases. Current Vascular Pharmacology. 6(3). 204–217. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026